Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
5.00
-0.04 (-0.89%)
At close: May 12, 2025, 4:00 PM
5.00
0.00 (0.00%)
After-hours: May 12, 2025, 6:30 PM EDT
Cryo-Cell International Market Cap
Cryo-Cell International has a market cap or net worth of $40.41 million as of May 12, 2025. Its market cap has decreased by -36.66% in one year.
Market Cap
40.41M
Enterprise Value
51.16M
1-Year Change
-36.66%
Ranking
Category
Stock Price
$5.00
Market Cap Chart
Since December 1, 1998, Cryo-Cell International's market cap has increased from $21.70M to $40.41M, an increase of 86.22%. That is a compound annual growth rate of 2.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 40.80M | -31.66% |
| Dec 31, 2024 | 59.70M | 25.42% |
| Dec 29, 2023 | 47.60M | 32.22% |
| Dec 30, 2022 | 36.00M | -63.60% |
| Dec 31, 2021 | 98.90M | 70.22% |
| Dec 31, 2020 | 58.10M | 4.50% |
| Dec 31, 2019 | 55.60M | -4.96% |
| Dec 31, 2018 | 58.50M | -14.85% |
| Dec 29, 2017 | 68.70M | 121.61% |
| Dec 30, 2016 | 31.00M | 6.90% |
| Dec 31, 2015 | 29.00M | 21.34% |
| Dec 31, 2014 | 23.90M | 20.10% |
| Dec 31, 2013 | 19.90M | -14.96% |
| Dec 31, 2012 | 23.40M | -0.43% |
| Dec 30, 2011 | 23.50M | -16.67% |
| Dec 31, 2010 | 28.20M | 34.93% |
| Dec 31, 2009 | 20.90M | 326.53% |
| Dec 31, 2008 | 4.90M | -46.74% |
| Dec 31, 2007 | 9.20M | -65.28% |
| Dec 29, 2006 | 26.50M | -32.91% |
| Dec 30, 2005 | 39.50M | -19.22% |
| Dec 31, 2004 | 48.90M | 431.52% |
| Dec 31, 2003 | 9.20M | -50.27% |
| Dec 31, 2002 | 18.50M | -65.80% |
| Dec 31, 2001 | 54.10M | 132.19% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |